Acute myeloid leukemia with 4q12 rearrangements involving CHIC2 : “pitfalls” in fluorescence in situ hybridization diagnosis of PDGFRA rearrangements
American Journal of Clinical Pathology · 04.08.2026 · 166 (2)
DOI: 10.1093/ajcp/aqag084 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 05.08.2026. Verfasst von Long Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sino-US Diagnostics Lab, Tianjin Enterprise Key Laboratory of AI-aided Hematopathology Diagnosis, Tianjin, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Receptor, Platelet-Derived Growth Factor alpha, Chromosomes, Human, Pair 4. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Key Research and Development Program of Tianjin.
Abstract (Originalsprache)
Objectives
Chromosome 4q12 rearrangements are recurrent in hematologic malignancies, most frequently involving PDGFRA. Fluorescence in situ hybridization (FISH) is routinely used for detecting 4q12 rearrangements. This study aimed to clarify 4q12 rearrangements misdiagnosed by FISH and explore the transcriptomic profile of acute myeloid leukemia (AML) with CHIC2 rearrangements.
Methods
Fluorescence in situ hybridization with a PDGFRA/CHIC2/FIP1L1 probe set detected 4q12 rearrangements. RNA sequencing (RNA-seq) characterized fusion transcripts and compared transcriptomic profiles between CHIC2-rearranged AML and NPM1-mutated controls, identifying differentially expressed genes and enriched pathways. Previously reported PDGFRA-independent 4q12 cases were reviewed.
Results
RNA sequencing of 2 AML cases with FISH signals suggestive of PDGFRA rearrangement identified CHIC2 fusions instead: a novel CDK6::CHIC2 and a known ETV6::CHIC2. Integrating our cases with a systematic literature review, we identified 41 hematologic neoplasms with PDGFRA-independent 4q12 rearrangements, of which 38 (92.7%) were AML. The 4q12 breakpoints most frequently involved CHIC2 (27 cases, 65.9%), followed by GSX2, SCFD2, and intergenic regions. Among 15 cases assessed by both FISH and molecular methods, FISH misclassified 9 (60.0%; 9/15) as PDGFRA rearranged; subsequent molecular testing revealed rearrangements of genes adjacent to PDGFRA (eg, CHIC2, GSX2) or intergenic regions. Transcriptomic profiling of CHIC2-rearranged AML revealed a distinct expression signature with 492 differentially expressed genes, including PDGFRA upregulation. Pathway analysis showed significant enrichment for cytokine-cytokine receptor interaction and JAK-STAT signaling (false discovery rate <0.05).
Conclusions
Molecular methods such as RNA-seq are effective for resolving cryptic 4q12 rearrangements in cases where FISH falsely suggests PDGFRA involvement. The distinct transcriptional profile of CHIC2-rearranged AML suggests dysregulated cytokine signaling and JAK-STAT activity in its pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sino-US Diagnostics Lab, Tianjin Enterprise Key Laboratory of AI-aided Hematopathology Diagnosis, Tianjin, China.
- Department of Pathology and Lab Medicine, Shandong Cancer Hospital, Jinan, Shandong, China.
Förderung
- Key Research and Development Program of Tianjin
Zitieren
APA
Chen, L., Zhang, H., Chai, S., Yang, S., Yao, J., Hou, X., Tian, X., Liu, E., Lin, Y., & Ru, K. (2026). Acute myeloid leukemia with 4q12 rearrangements involving CHIC2 : “pitfalls” in fluorescence in situ hybridization diagnosis of PDGFRA rearrangements. American Journal of Clinical Pathology, 166(2). https://doi.org/10.1093/ajcp/aqag084
Vancouver
Chen L, Zhang H, Chai S, Yang S, Yao J, Hou X, et al. Acute myeloid leukemia with 4q12 rearrangements involving CHIC2 : “pitfalls” in fluorescence in situ hybridization diagnosis of PDGFRA rearrangements. American Journal of Clinical Pathology. 2026;166(2). doi:10.1093/ajcp/aqag084
BibTeX
@article{Chen2026,
author = {Chen, Long and Zhang, Hong and Chai, Sasa and Yang, Shaobin and Yao, Jingya and Hou, Xiaoju and Tian, Xin and Liu, Enbin and Lin, Yani and Ru, Kun},
title = {Acute myeloid leukemia with 4q12 rearrangements involving CHIC2 : “pitfalls” in fluorescence in situ hybridization diagnosis of PDGFRA rearrangements},
journal = {American Journal of Clinical Pathology},
year = {2026},
volume = {166},
number = {2},
doi = {10.1093/ajcp/aqag084}
}
EUVIMED